ONMD OneMedNet Corp Class A Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ONMD
—
—
Key stats
Related
About
- Industry (SIC)
- SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH (8731) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 23
- List Date
- 2023-11-08
- CIK
- 0001849380
- Next Earnings
- 2026-11-13
- Headquarters
- Surrey, X0
- Homepage
- https://www.onemednet.com
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-c…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|
| Jan | -- | 155.06% | -25.90% | -37.34% | 30.61% |
| Feb | -- | -41.23% | -10.00% | 31.78% | -6.48% |
| Mar | -- | -11.08% | -40.63% | 13.03% | -12.89% |
| Apr | -- | -22.54% | -30.99% | 28.01% | -8.51% |
| May | -- | 328.70% | -4.76% | -22.57% | 100.46% |
| Jun | -- | -52.07% | 50.03% | -8.78% | -3.61% |
| Jul | -- | 51.13% | -16.33% | -1.26% | 11.18% |
| Aug | -- | -23.70% | 78.42% | -22.42% | 10.77% |
| Sep | -- | -38.31% | 25.71% | 1.10% | -3.83% |
| Oct | -- | 48.10% | 105.83% | -11.09%* | 47.61% |
| Nov | -19.47% | 15.76% | 4.52% | -- | 0.27% |
| Dec | -80.43% | 27.10% | -25.17% | -- | -26.17% |
| Total | -84.24% | 228.84% | 17.95% | -41.89% | 30.16% |
* Only 4 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $4.98
SMA 50: $5.81
SMA 200: $7.41
Current: $4.97
EMA 12: $4.78
EMA 26: $5.18
MACD: -0.3928 | Signal: 0.0520
BEARISH
ADX (14): 18.90
RANGE
+DI: 22.86
−DI: 25.23
Momentum Oscillators
RSI (14): 46.73
NEUTRAL
Stoch %K: 57.06
Stoch %D: 49.49
Williams %R: -28.80
Volume & Volatility
BB Upper: $6.29
BB Lower: $3.68
NEUTRAL
OBV: 137,981,678
Vol SMA 20: 63,575
Vol ROC: 41.41%
ATR: $0.45
True Range: $0.46
HV 20: 124.0%
HV 30: 114.9%
HV 60: 112.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-23T00:00:00 – 2026-10-21T00:00:00
AI Analysis
LLM Stock Analysis Report: ONMD
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Technical indicators suggest a bearish trend, with MACD indicating a potential sell signal.
- Momentum oscillators are neutral, with RSI at 40.85 and Williams %R at -99.75.
- Bollinger Bands indicate a neutral volatility regime.
Primary Risks:
- High volatility and beta of 1.02 amplify market movements.
- Recent earnings history is limited, making it difficult to assess the company's financial performance.
Recent News Sentiment Impact: No recent news headlines available.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): BEARISH Medium-term (1-3 months): NEUTRAL Long-term (3-12 months): NEUTRAL
Support/Resistance Levels:
- SMA 20: $1.50
- SMA 50: $1.67
- SMA 200: $0.95
- Upper Bollinger Band: $1.97
- Middle Bollinger Band: $1.50
- Lower Bollinger Band: $1.02
Momentum Signals:
- MACD signal line is bearish, indicating a potential sell signal.
- RSI (14) is at 40.85, suggesting neutral momentum.
- Stochastic %K and %D are below their respective mean levels.
Volume Analysis: Volume SMA 20: 614910.40 On-Balance Volume (OBV): 1142404127.00 Volume Rate of Change: -46.96%
News & Sentiment Analysis
Recent Headlines Summary: No recent news headlines available.
Sentiment Assessment: NEUTRAL
Catalyst Identification:
- Most Recent Earnings Date: 2024-12-30
- Recent Earnings History: 2024-12-30, 2024-11-27, 2024-09-12
Market Narrative: The lack of recent news headlines and limited earnings history make it challenging to assess the company's financial performance.
Risk & Volatility Assessment
Risk Assessment:
- Beta: 1.02 (above average)
- Stock Volatility: 2.42 (above average)
Volatility Regime: NEUTRAL (Bollinger Bands indicate a neutral volatility regime).
Options Market Signals: No options data available.
Downside Protection: Support levels and risk management considerations are necessary due to the high volatility and beta of 1.02.
Market Context & Positioning
Sector Performance:
- Relative strength vs sector/market is not available (no recent news headlines or earnings history).
Institutional Activity: Institutional interest signals are unavailable (no options data available).
Correlation Analysis: R-squared interpretation suggests that the stock moves relative to market, with a correlation coefficient of 0.08.
Relative Valuation:
- Position within trading range is difficult to determine due to limited recent price action and no earnings history available.
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $1.50
- SMA 50: $1.67
- Lower Bollinger Band: $1.02
Breakout/Breakdown Levels:
- Upper Bollinger Band: $1.97 (potential resistance)
- Middle Bollinger Band: $1.50 (potential support)
Time-Sensitive Catalysts: Most Recent Earnings Date: 2024-12-30 (near-term catalyst)
Risk Management: Stop-loss levels and position sizing considerations are necessary due to the high volatility and beta of 1.02.
Confidence Level: 6/10 (due to limited recent news headlines, earnings history, and options activity).
Generated
News
All ONMD news →
ONMD Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 0.6630
Alpha: -84.46%
Correlation: 0.0648
R-Squared: 0.4%
Stock Volatility: 130.6%
Market Volatility: 12.8%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
ONMD Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
ONMD Insider Trading (Form 4)
Latest: 2026-10-13Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Jeffrey Yu | Chief Medical Officer | Buy (P) | +45,126 | $5.54 | $250.0K | EDGAR |
| 2026-10-13 | Thomas Kosasa | Director | Buy (P) | +129,758 | $5.78 | $750.0K | EDGAR |
| 2026-10-09 | Robert Lawrence Golden | Chief Financial Officer | Mixed | +36,500 | $6.50 | -$55.3K | EDGAR |
| 2026-10-09 | Aaron Green | Chief Executive Officer | Mixed | +58,333 | $7.16 | -$47.8K | EDGAR |
| 2026-09-14 | Jeffrey Yu | Chief Medical Officer | Buy (P) | +142,857 | $0.63 | $90.0K | EDGAR |
| 2026-08-07 | Thomas Kosasa | Director | Buy (P) | +1,449,275 | $0.69 | $1000.0K | EDGAR |
| 2026-08-07 | Thomas Kosasa | Director | Buy (P) | +1,449,275 | $0.69 | $1000.0K | EDGAR |
| 2026-06-24 | Jeffrey Yu | Chief Medical Officer | Buy (P) | +158,730 | $0.63 | $100.0K | EDGAR |
| 2026-06-24 | Aaron Green | Chief Executive Officer | Buy (P) | +36,650 | $0.57 | $21.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ONMD Insider Holdings
4 insiders · @ $4.97
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Thomas Kosasa | Director | 1,983,573 | $9.86M | $2.75M | 3 | 2026-10-13 |
| 2 | Jeffrey Yu | Chief Medical Officer | 1,028,037 | $5.11M | $440.0K | 3 | 2026-10-13 |
| 3 | Aaron Green | Chief Executive Officer | 247,971 | $1.23M | -$26.8K | 2 | 2026-10-09 |
| 4 | Robert Lawrence Golden | Chief Financial Officer | 94,291 | $468.6K | -$55.3K | 1 | 2026-10-09 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ONMD Board & Officers
As of SEC filings through Oct 13, 2026Directors 8
- Aaron Green · since Nov 7, 2023
- Eric Casaburi · since Nov 7, 2023
- Jeffrey Yu · since Nov 7, 2023
- Robert Lawrence Golden · since Nov 7, 2023
- Andrew B Zeinfeld · since Aug 14, 2024
- Jair Clarke · since Oct 1, 2024
- Sherry Coonse McCraw · since Oct 1, 2024
- Kenneth Alleyne · since Feb 25, 2025
Officers 3
- Aaron Green · Chief Executive Officer · since Nov 7, 2023
- Robert Lawrence Golden · Chief Financial Officer · on file since Nov 2025
- Jeffrey Yu · Chief Medical Officer · since Nov 7, 2023
10% owners 2
- Jeffrey Yu · listed since Apr 2026
- Thomas Kosasa · listed since Apr 2026
Changes in the last 10 years (33)
| Apr 24, 2026 | Thomas Kosasa first listed as a 10% owner in an SEC filing |
| Apr 24, 2026 | Jeffrey Yu first listed as a 10% owner in an SEC filing |
| Nov 26, 2025 | Thomas Kosasa no longer listed as a 10% owner in SEC filings |
| Nov 26, 2025 | Robert Lawrence Golden first on file as Chief Financial Officer |
| Feb 25, 2025 | Kenneth Alleyne became a director |
| Oct 1, 2024 | The company announced the departure of Paul Casey from the board in an SEC filing |
| Oct 1, 2024 | Sherry Coonse McCraw became a director |
| Oct 1, 2024 | Jair Clarke became a director |
| Aug 14, 2024 | Andrew B Zeinfeld became a director |
| Mar 27, 2024 | The company announced the departure of Thomas Kosasa from the board in an SEC filing |
| Mar 27, 2024 | The company announced the departure of Paul Casey as Chief Executive Officer in an SEC filing |
| Nov 8, 2023 | Thomas Kosasa became a director |
| Nov 8, 2023 | Thomas Kosasa became a 10% owner |
| Nov 8, 2023 | Paul Casey became a director |
| Nov 8, 2023 | Paul Casey became Chief Executive Officer |
| Nov 7, 2023 | Robert Lawrence Golden became a director |
| Nov 7, 2023 | Jeffrey Yu became a director |
| Nov 7, 2023 | Jeffrey Yu became Chief Medical Officer |
| Nov 7, 2023 | Eric Casaburi became a director |
| Nov 7, 2023 | Aaron Green became a director |
| Nov 7, 2023 | Aaron Green became Chief Executive Officer |
| Aug 21, 2023 | Owl Creek Asset Management, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 21, 2023 | Jeffrey A Altman reported in an SEC filing no longer being a 10% owner |
| Nov 18, 2022 | Shaolin Capital Management LLC became a 10% owner |
| Nov 15, 2022 | Owl Creek Asset Management, L.P. became a 10% owner |
| Nov 15, 2022 | Jeffrey A Altman became a 10% owner |
| May 6, 2021 | Syed Ahmed became a director |
| May 6, 2021 | Julianne Huh became a director |
| May 6, 2021 | Firdauz Mokhtar became Chief Financial Officer |
| May 6, 2021 | Data Knights, LLC became a 10% owner |
| May 6, 2021 | Barry James Anderson became a director |
| May 6, 2021 | Barry James Anderson became Chief Executive Officer |
| May 6, 2021 | Annie Undikai became a director |
Not reported recently (7)
- Julianne Huh · Last reported as a director in an SEC filing dated Oct 17, 2023
- Shaolin Capital Management LLC · Last reported as a 10% owner in an SEC filing dated Jan 13, 2023
- Barry James Anderson · Last reported as a director in an SEC filing dated May 13, 2021
- Data Knights, LLC · Last reported as a 10% owner in an SEC filing dated May 11, 2021
- Firdauz Mokhtar · Last reported as Chief Financial Officer in an SEC filing dated May 7, 2021
- Syed Ahmed · Last reported as a director in an SEC filing dated May 7, 2021
- Annie Undikai · Last reported as a director in an SEC filing dated May 7, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
4 ETFs hold ONMD
4 shown · $687.50K total exposure · 0.00% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $488,856 | — | 2026-09-30 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $177,698 | — | 2026-09-30 |
| 3 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.00% | $20,513 | $1.2B | 2026-10-20 |
| 4 | AVTM Avantis Total Equity Markets ETF | Avantis | 0.00% | $429 | $781.4M | 2026-10-20 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.